NEW YORK — Novacyt on Monday reported a 906 percent year-over-year increase in unaudited revenues for the first half of 2020, driven by strong demand for COVID-19 testing.
For the six months ended 30 June, the Paris-based company reported unaudited revenues of €72.4 million ($82 million) compared to €7.2 million for the first half of 2019. The firm said it booked 91 percent of the revenues in the second quarter.